NZ's Truscreen gains after relaunch of cancer screening device in China

Truscreen

10/08/2022 03:53

** Shares of New Zealand-based medical device co Truscreen
Group Ltd  TRU.NZ  rise as much as 4.2% to NZ$0.05, set for best
day since Aug 3, if gains hold
    ** Co announces relaunch distribution of its medical
cervical cancer screening devices via its Chinese distributor in
Xinjiang Uygur Autonomous Region  urn:newsml:reuters.com:*:nNZW3pQgnL
    ** The project was put on hold and further delayed by the
COVID-19 pandemic
    ** Adds that initial order of 20 devices has been delivered
    ** More than 254,000 shares change hands, compared with the
30-day average volume of about 214,000 shares
    ** Truscreen stock down 41.5% this year, as of last close
 

 (Reporting by Jaskiran Singh in Bengaluru)
 ((Jaskiran.Singh@thomsonreuters.com;))